PMV Pharmaceuticals, Inc.
PMVP
DELAYED 1 MONTH

9 insider filings · Latest: Jun 4, 2026

Common Stock Transactions

No transactions found.

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jun 4, 2026Jun 5 8:32 PMLaurie StelzerDirector
Grant/Award
42,000$1.1942,000(D)

View →

Jun 4, 2026Jun 5 8:30 PMArnold J LevineDirector
Grant/Award
42,000$1.1942,000(D)

View →

Jun 4, 2026Jun 5 8:25 PMCarol Giltner GallagherDirector
Grant/Award
42,000$1.1942,000(D)

View →

Jun 4, 2026Jun 5 8:25 PMCarol Giltner GallagherDirector
Gift
42,000$1.1942,000(I)

View →

Jun 4, 2026Jun 5 8:25 PMCarol Giltner GallagherDirector
Gift
42,000$1.190(D)

View →

Jun 4, 2026Jun 5 8:23 PMKirsten FlowersDirector
Grant/Award
42,000$1.1942,000(D)

View →

Jun 4, 2026Jun 5 8:20 PMCharles M BaumDirector
Grant/Award
42,000$1.1942,000(D)

View →

Mar 5, 2026Mar 9 8:41 PMMichael CarulliChief Financial Officer
Grant/Award
240,000$1.53240,000(D)

View →

Mar 5, 2026Mar 9 8:39 PMRobert TicktinGeneral Counsel & COO
Grant/Award
319,270$1.53319,270(D)

View →

Mar 5, 2026Mar 9 8:36 PMDeepika JalotaChief Development Officer
Grant/Award
303,310$1.53303,310(D)

View →

Mar 5, 2026Mar 9 8:35 PMDavid Henry MackDirector, President and CEO
Grant/Award
744,960$1.53744,960(D)

View →